Literature DB >> 34171236

Photons, Protons, SBRT, Brachytherapy-What Is Leading the Charge for the Management of Prostate Cancer? A Perspective From the GU Editorial Team.

Ananya Choudhury1, Ann Henry Md Frcr2, Timur Mitin Md PhD3, Ronald Chen Md Mph4, Nuradh Joseph Md Frcr5, Daniel E Spratt Md PhD6.   

Abstract

Entities:  

Year:  2021        PMID： 34171236     DOI： 10.1016/j.ijrobp.2021.01.003

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  3 in total

1.  Ultrahypofractionated Radiotherapy versus Conventional to Moderate Hypofractionated Radiotherapy for Clinically Localized Prostate Cancer.

Authors:  Hideya Yamazaki; Gen Suzuki; Norihiro Aibe; Daisuke Shimizu; Takuya Kimoto; Koji Masui; Ken Yoshida; Satoaki Nakamura; Yasutoshi Hashimoto; Haruumi Okabe
Journal:  Cancers (Basel)       Date:  2021-12-31       Impact factor: 6.639

2.  Mixed-Beam Approach for High-Risk Prostate Cancer Carbon-Ion Boost Followed by Photon Intensity-Modulated Radiotherapy: Preliminary Results of Phase II Trial AIRC-IG-14300.

Authors:  Giulia Marvaso; Barbara Vischioni; Matteo Pepa; Mattia Zaffaroni; Stefania Volpe; Filippo Patti; Federica Bellerba; Sara Gandini; Stefania Comi; Giulia Corrao; Dario Zerini; Matteo Augugliaro; Cristiana Fodor; Stefania Russo; Silvia Molinelli; Mario Ciocca; Rosalinda Ricotti; Francesca Valvo; Tommaso Giandini; Barbara Avuzzi; Riccardo Valdagni; Ottavio De Cobelli; Federica Cattani; Ester Orlandi; Barbara Alicja Jereczek-Fossa; Roberto Orecchia
Journal:  Front Oncol       Date:  2021-11-17       Impact factor: 6.244

3.  Comparison of toxicities between ultrahypofractionated radiotherapy versus brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer.

Authors:  Hideya Yamazaki; Koji Masui; Gen Suzuki; Norihiro Aibe; Daisuke Shimizu; Takuya Kimoto; Kei Yamada; Akihisa Ueno; Toru Matsugasumi; Yasuhiro Yamada; Takumi Shiraishi; Atsuko Fujihara; Ken Yoshida; Satoaki Nakamura
Journal:  Sci Rep       Date:  2022-03-23       Impact factor: 4.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.